Notice of Clarification for RFA-AI-10-027 Biomedical Prevention of HIV Research Education (R25)


Notice Number: NOT-AI-10-043

Key Dates

Release Date:  September 30, 2010

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to provide clarification to sections of the National Institute of Allergy and Infectious Diseases (NIAID) FOA, RFA-AI-10-027 http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-10-027.html  entitled “Biomedical Prevention of HIV Research Education”. 

The first two changes are to increase the funds available for this FOA to commit approximately $2.2M in fiscal year 2011 to fund 1 application and to clarify that the cost refers to Total Cost and not to Direct Cost.  

Below, the relevant sections of the FOA are changed with the appropriate dollar figure.  All costs in the FOA have been changed to Total Cost.

The third change is to add a reference to the NIAID HIV Vaccine Research Education Initiative (NHVREI) is now provided to inform applicants of previous activities funded by NIAID and the altered paragraph is included below.

The fourth and final change is a modification to the definition of participants to better reflect the intent of this award and the recognition that the persons to be trained by this education grant are a wider community.

Executive Summary

OLD LANGUAGEBudget and Project Period: Budgets for direct costs up to $1.8M per year and project duration of up to five years may be requested for a maximum of $9.0M direct costs, over a five-year project period. 

NEW LANGUAGE:  Budget and Project Period: Budgets for total costs up to $2.2M per year and project duration of up to five years may be requested for a maximum of $11.0M total costs, over a five-year project period.

OLD LANGUAGE: Funds Available and Anticipated Number of Awards: The NIAID intends to commit up to $1.8M in total funding in FY2011 to fund one award in response to this FOA. An award issued under this FOA is contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

NEW LANGUAGE: Funds Available and Anticipated Number of Awards. NIAID intends to commit approximately $2.2M in total costs in FY 2011 to fund one application submitted in response to this FOA. Awards issued under this FOA are contingent upon the availability of funds.

Section II Award information

2. Funds Available

OLD LANGUAGE: The total project period for an application submitted in response to this funding opportunity may not exceed 5 years. Although the size of award may vary with the scope of the research education program proposed, it is expected that applications will stay within the following budgetary guidelines: total costs are limited to $1.8M annually.

NEW LANGUAGE: The total project period for an application submitted in response to this funding opportunity may not exceed 5 years. NIAID intends to commit approximately $2.2M total cost for this FOA for fiscal year 2011 to fund 1 application.

Part II - Full Text of Announcement

Section I. Funding Opportunity Description

Research Education Objectives

OLD LANGUAGE: Paragraph 3: NIAID has worked since 2000 to educate U.S. populations about HIV vaccine research, first through the HIV Vaccine Communication Campaign, and beginning in 2006 through the NIAID HIV Vaccine Research Education Initiative (NHVREI).  This FOA is to establish the successor to NHVREI and to expand the scope to include education about all types of biomedical HIV prevention clinical research rather than focusing solely on HIV vaccine research.   The goal of the Biomedical Prevention of HIV Research Education (B-PHRE, pronounced “be free”) is to create an enabling environment for biomedical HIV clinical prevention research, including vaccine research, particularly among those U.S. populations most affected by HIV/AIDS.

NEW LANGUAGE: Paragraph 3: NIAID has worked since 2000 to educate U.S. populations about HIV vaccine research, first through the HIV Vaccine Communication Campaign, and beginning in 2006 through the NIAID HIV Vaccine Research Education Initiative (NHVREI).  Background information about NHVREI and findings from formative research conducted by NHVREI are available at http://bethegeneration.nih.gov/go/info. This FOA is to establish the successor to NHVREI and to expand the scope to include education about all types of biomedical HIV prevention clinical research rather than focusing solely on HIV vaccine research.   The goal of the Biomedical Prevention of HIV Research Education (B-PHRE, pronounced “be free”) is to create an enabling environment for biomedical HIV clinical prevention research, including vaccine research, particularly among those U.S. populations most affected by HIV/AIDS.

OLD LANGUAGE: 3. Other-Special Eligibility Criteria:  Participants: Describe who the intended participants are, and the eligibility and/or specific educational background characteristics that are essential for participation in the proposed research education program. Identify the career levels essential for participation in the planned program.  For the purpose of this FOA, “participants” refers to those receiving the education and outreach about biomedical HIV prevention research are scientists and educators, media experts, community leaders, and members of stakeholder organizations engaged in biomedical HIV prevention research among highly HIV-affected communities in the United States.  These individuals must be members or influencers of highly affected communities and those involving HIV-impacted populations in the U.S. as indicated by surveillance data from the U.S. Centers for Disease Control and Prevention (see http://www.cdc.gov/hiv/topics/surveillance/index.htm for more information).

NEW LANGUAGE: 3. Other-Special Eligibility Criteria:  Participants: For the purpose of this FOA, “participants” refers to those receiving the education and outreach about biomedical HIV prevention research.  These individuals must be members or influencers of highly HIV-impacted populations in the U.S. as indicated by surveillance data from the U.S. Centers for Disease Control and Prevention (see http://www.cdc.gov/hiv/topics/surveillance/index.htm for more information).

NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made in response to this FOA.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Katharine Kripke, Ph.D.
Division of AIDS
National Institute of Allergy and Infectious Diseases
Room 5144, MSC-7628
6700-B Rockledge Drive
Bethesda, MD 20892-7628
Telephone: (301) 402-0846
Fax: 301-402-3684
Email: kripkek@niaid.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.